CD36 plays a significant role in the development and progression of various cancer types, including breast cancer [58], acute myeloid leukaemia [59], and gastric cancer [60], through several mechanisms, such as the activation of cancer stem cells, epithelial-to-mesenchymal transition, and enhancing chemoresistance [61, 62]. This evidence concerns the gene CD36 and acute myeloid leukemia.